chr14-58396045-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_207377.3(TOMM20L):āc.88A>Gā(p.Asn30Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000982 in 1,425,280 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_207377.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOMM20L | NM_207377.3 | c.88A>G | p.Asn30Asp | missense_variant | 1/5 | ENST00000360945.7 | NP_997260.1 | |
TOMM20L | XM_011536742.4 | c.88A>G | p.Asn30Asp | missense_variant | 1/5 | XP_011535044.1 | ||
TOMM20L | XM_011536743.3 | c.88A>G | p.Asn30Asp | missense_variant | 1/5 | XP_011535045.1 | ||
TOMM20L | XM_011536744.4 | c.88A>G | p.Asn30Asp | missense_variant | 1/3 | XP_011535046.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOMM20L | ENST00000360945.7 | c.88A>G | p.Asn30Asp | missense_variant | 1/5 | 1 | NM_207377.3 | ENSP00000354204.2 | ||
TOMM20L | ENST00000557754.1 | n.88A>G | non_coding_transcript_exon_variant | 1/4 | 1 | ENSP00000451683.1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151620Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000471 AC: 6AN: 1273554Hom.: 0 Cov.: 31 AF XY: 0.00000478 AC XY: 3AN XY: 627862
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151726Hom.: 1 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74176
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at